NEW YORK (GenomeWeb) – Qiagen has extended the offer period for its DKK683 million ($103.5 million) acquisition of Exiqon. It announced in late March a voluntary conditional public takeover offer to buy all of Exiqon's shares for DKK18 per share, and as of the end of the day on May 18 had received acceptances from shareholders in Exiqon representing around 81 percent of the share capital and voting rights in the firm. Qiagen said the offer now expires at the end of the day on June 2.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.